| COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders | 2021-08-13 | 2023-06-22 | |
| An Evaluation of Repeated Oral Doses of JNJ-64281802 Against DENV-3 Challenge | 2022-02-03 | 2023-05-16 | |
| Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study) | 2021-02-19 | 2023-03-16 | 2024-03-15 |
| Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants | 2019-07-22 | 2023-03-13 | 2024-03-12 |
| Vaccination for Recovered Inpatients With COVID-19 (VATICO) | 2021-08-25 | 2022-12-21 | 2024-02-13 |
| Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine | 2022-09-09 | 2022-12-01 | 2023-11-30 |
| COVID-19 Protection After Transplant Pilot Study | 2021-08-10 | 2022-11-10 | 2023-12-19 |
| Selective CD28 Blockade in Renal Transplant Recipients | 2022-01-10 | 2022-09-22 | |
| A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and Rifabutin | 2020-10-27 | 2022-08-30 | 2023-08-30 |
| ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19 | 2021-04-20 | 2022-08-22 | |
| Cockroach Immunotherapy in Children and Adolescents | 2018-07-16 | 2022-06-02 | 2023-02-21 |
| ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19 | 2021-08-03 | 2022-04-23 | 2023-04-13 |
| ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 | 2020-10-23 | 2022-04-22 | 2023-04-13 |
| COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations | 2021-04-07 | 2022-04-20 | 2023-04-13 |
| ACTIV-2: A Study for Outpatients With COVID-19 | 2020-08-19 | 2022-04-07 | 2023-04-07 |
| ACTIV-3: Therapeutics for Inpatients With COVID-19 | 2020-08-04 | 2022-04-06 | |
| PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | 2021-09-15 | 2022-04-06 | 2024-01-12 |
| SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine | 2021-07-09 | 2022-02-28 | 2023-02-22 |
| MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | 2021-06-11 | 2022-02-23 | 2024-01-09 |
| COVID-19 and Anti-CD14 Treatment Trial | 2021-04-12 | 2022-02-04 | 2023-04-06 |
| AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | 2021-02-05 | 2022-01-28 | |
| A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine | 2021-03-24 | 2021-12-30 | 2023-05-30 |
| Suppression Of Bacterial Vaginosis (BV) [SUBVert] | 2019-09-09 | 2021-12-06 | 2022-11-11 |
| Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa | 2016-10-26 | 2021-11-16 | 2022-11-16 |
| ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19 | 2020-10-23 | 2021-09-13 | 2022-09-13 |
| NNITS-Nitazoxanide for Norovirus in Transplant Patients Study | 2018-10-15 | 2021-08-24 | 2022-08-18 |
| JBT-101 in Systemic Lupus Erythematosus (SLE) | 2017-12-21 | 2021-07-28 | 2022-07-28 |
| VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | 2020-12-16 | 2021-06-09 | 2023-10-26 |
| BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | 2020-12-16 | 2021-06-08 | 2024-01-08 |
| Adaptive COVID-19 Treatment Trial 4 (ACTT-4) | 2020-12-02 | 2021-05-18 | 2022-04-14 |
| A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children | 2017-11-07 | 2021-04-20 | 2022-04-20 |
| LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | 2020-08-05 | 2021-02-01 | 2023-07-21 |
| Adaptive COVID-19 Treatment Trial 3 (ACTT-3) | 2020-08-05 | 2020-12-21 | 2021-10-28 |
| Asymptomatic Congenital CMV Treatment | 2019-08-21 | 2020-11-05 | 2022-11-29 |
| Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants | 2018-01-19 | 2020-10-03 | 2021-10-04 |
| Adaptive COVID-19 Treatment Trial 2 (ACTT-2) | 2020-05-08 | 2020-07-31 | 2021-02-25 |
| Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 | 2020-05-13 | 2020-07-08 | 2021-02-24 |
| 2017 A/H7N9 IIV Revaccination | 2018-12-18 | 2020-06-19 | 2021-06-10 |
| 2013/2017 H7N9 Prime-Boost Interval | 2018-08-21 | 2020-06-14 | 2021-06-03 |
| Adaptive COVID-19 Treatment Trial (ACTT) | 2020-02-21 | 2020-05-21 | 2020-09-16 |
| Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults | 2018-10-23 | 2020-05-15 | 2021-11-24 |
| Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza | 2018-11-02 | 2020-04-30 | 2021-04-22 |
| Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis | 2018-07-25 | 2020-04-03 | 2021-04-02 |
| Analysis of Bone Marrow and Blood B Cell Immune Responses to Influenza Vaccination | 2015-12-23 | 2020-03-31 | 2021-12-30 |
| Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation | 2015-12-15 | 2020-02-10 | 2021-02-10 |
| Age and Response to Flu Vaccines | 2017-12-14 | 2020-02-09 | 2021-04-29 |
| Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss | 2015-02-24 | 2019-12-24 | 2020-12-23 |
| Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children | 2016-12-02 | 2019-12-16 | 2020-12-10 |
| Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers | 2015-04-01 | 2019-12-06 | 2022-02-24 |
| Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND) | 2016-04-21 | 2019-12-02 | 2021-12-17 |